Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2401 to 2415 of 7711 results

  1. Artificial intelligence software to help detect and characterise colorectal polyps

    In development [GID-DG10118] Expected publication date: 22 January 2026

    Diagnostics guidance
    In development

  2. Teprotumumab for treating thyroid eye disease [ID6432]

    In development [GID-TA11531] Expected publication date: 20 August 2025

    Technology appraisal guidance
    In development

  3. Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer [ID6177]

    In development [GID-TA11140] Expected publication date: 23 July 2025

    Technology appraisal guidance
    In development

  4. Epcoritamab for treating relapsed or refractory follicular lymphoma ID6338

    In development [GID-TA11385] Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Sparsentan for treating primary IgA nephropathy [ID6308]

    In development [GID-TA11359] Expected publication date: 30 April 2025

    Technology appraisal guidance
    In development

  6. Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma [ID5123]

    In development [GID-TA11316] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. NVK-002 for treating myopia in people 3 to 17 years TSID 11961

      Status ...

    Technology appraisal guidance
    Topic selection

  8. Low-dose atropine eye drops for treating myopia in people 3 to 14 years [ID6517]

      Status ...

    Technology appraisal guidance
    Topic selection

  9. Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over [ID6130]

    In development [GID-HST10059] Expected publication date: TBC

    Highly specialised technologies guidance
    In development

  10. Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease

    In development [GID-IPG10345] Expected publication date: 17 April 2025

    Interventional procedures guidance
    In development

  11. Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]

    In development [GID-TA11484] Expected publication date: TBC

    Technology appraisal guidance
    In development

  12. Inebilizumab for treating immunoglobulin G4-related disease [TS ID 12107]

    Awaiting development [GID-TA11665] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Inebilizumab for treating generalised myasthenia gravis [TS ID 12110]

    Awaiting development [GID-TA11667] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Sibeprenlimab for treating IgA nephropathy [TS ID 12111]

    Awaiting development [GID-TA11668] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Upadacitinib for treating giant cell arteritis [ID6299]

    Awaiting development [GID-TA11330] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development